Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

LSE:VOD
LSE:VODWireless Telecom

Vodafone Buyback Completion Puts Capital Allocation And Valuation In Focus

Vodafone Group (LSE:VOD) has completed its latest share buyback program, initiated in late 2025. The buyback forms part of the company’s broader approach to capital allocation and shareholder returns. This development is attracting attention from investors looking beyond quarterly earnings headlines. Vodafone Group, the multinational telecoms operator behind mobile and fixed connectivity services across multiple regions, sits in a sector where cash flow, spectrum spending and infrastructure...
TSXV:GMG
TSXV:GMGElectrical

Assessing Graphene Manufacturing Group’s Valuation As Interest Builds Around Emerging Growth Conference Presentation

Conference spotlight and why it matters for GMG shareholders Interest in Graphene Manufacturing Group (TSXV:GMG) has been building as investors look ahead to the company’s January 22 presentation at Emerging Growth Conference 89, where founder and CEO Craig Nicol is scheduled to speak. Conference appearances like this often put the spotlight on how management sees its business, products, and capital needs. This can shape how investors think about risk, potential dilution, and longer term...
NasdaqGS:SPSC
NasdaqGS:SPSCSoftware

Did SPS Commerce’s New Supply Chain Cloud Tools Just Shift SPSC’s Investment Narrative?

In January 2026, SPS Commerce, Inc. announced a set of new supply chain products and capabilities, including SAP S/4HANA cloud connectivity, Shopify system automation, the SPS Relationship Center, and an enhanced Manufacturing Suite to improve visibility and coordination across complex, diversified supply networks. An important insight from this launch is how SPS Commerce is positioning its network and tools as a shared operating layer for retailers, manufacturers, and suppliers that need...
ENXTAM:SBMO
ENXTAM:SBMOEnergy Services

SBM Offshore (ENXTAM:SBMO) Valuation Check After Barclays Upgrade And Growing Sector Optimism

Analyst upgrade puts SBM Offshore in focus A recent Barclays upgrade has pushed SBM Offshore (ENXTAM:SBMO) into the spotlight, with the bank citing expectations of positive company specific news and a more supportive backdrop for European energy services. See our latest analysis for SBM Offshore. The recent upgrade comes on the back of strong momentum, with a 20.8% 30 day share price return and a 32.3% 90 day share price return, while the 1 year total shareholder return of 72.0% points to...
LSE:ZEG
LSE:ZEGTelecom

UK Stocks Trading Below Estimated Value In January 2026

As the United Kingdom's FTSE 100 index faces pressure from weak trade data out of China, concerns about global economic recovery have been at the forefront of investors' minds. In such a climate, identifying stocks that are trading below their estimated value can present opportunities for investors seeking to navigate these challenging market conditions.
LSE:PTEC
LSE:PTECHospitality

Discovering Optima Health And 2 Other Promising UK Penny Stocks

The UK market has recently experienced some turbulence, with the FTSE 100 index closing lower amid weak trade data from China, highlighting ongoing global economic challenges. Despite such fluctuations, investors often look beyond blue-chip stocks to explore opportunities in smaller or newer companies that can offer unique value propositions. Penny stocks, a term that might seem outdated but still relevant today, represent these potential investments; they can provide intriguing prospects...
ENXTBR:SOLB
ENXTBR:SOLBChemicals

Assessing Solvay (ENXTBR:SOLB) Valuation After Recent Share Price Weakness

What recent performance says about Solvay Solvay (ENXTBR:SOLB) has drawn investor attention after a mixed run in its share price, with a 1.7% gain over the past day contrasting with weaker returns over the past month and past 3 months. That short term rebound comes after a 6.5% decline over the past month and a 10.3% drop over the past 3 months, while the 1 year total return is down 10.6% and the year to date performance shows a 7.8% decline. See our latest analysis for Solvay. The €25.22...
NasdaqGS:XRX
NasdaqGS:XRXTech

Is Xerox (XRX) Using Its Lexmark AI Retail Suite to Redefine Its Competitive Moat?

In January 2026, Xerox Holdings and Lexmark, now a combined company, unveiled a unified suite of AI-enabled retail technology solutions at NRF 2026: Retail’s Big Show in New York, highlighting end-to-end offerings spanning IT, production print, digital workflows, signage, and vision AI for store operations. This collaboration underscores how integrating Xerox’s digital workflow and print capabilities with Lexmark’s retail-focused devices and vision AI can create a single platform that...
TSX:WELL
TSX:WELLHealthcare

WELL Health 2026 Plan Highlights Tech Platform Growth And Clinic Execution

WELL Health Technologies (TSX:WELL) CEO issued a shareholder letter outlining the company’s outlook and growth priorities for 2026. The letter focuses on technology driven initiatives and the next phase of the company’s business evolution. Management highlighted key areas of focus for digital health services, clinic operations, and platform development. WELL Health Technologies, a Canadian digital health and clinic services company, operates at the intersection of software, virtual care,...
NYSE:LUMN
NYSE:LUMNTelecom

Has Lumen Technologies (LUMN) Run Too Far After Its Recent Share Price Rebound

If you are wondering whether Lumen Technologies at around US$8.39 still offers value or has already run too far, you are not alone. The stock shows returns of 2.2% over 7 days, 8.0% over 30 days, 9.1% year to date, 45.9% over 1 year and 58.3% over 3 years, while the 5 year return sits at a 36.9% decline. Recent attention on Lumen has been shaped by ongoing coverage of its turnaround efforts and balance sheet position, as investors weigh how the company responds to its debt load and industry...
NasdaqGS:CRNX
NasdaqGS:CRNXPharmaceuticals

Is It Too Late To Consider Crinetics Pharmaceuticals (CRNX) After Strong Multi‑Year Share Gains?

Investors may be wondering if Crinetics Pharmaceuticals at around US$55.41 per share is still offering fair value, or if the recent excitement has already been priced in. The stock shows a flat 7 day return, while the 30 day return is 12.5%, year to date is 18.6%, and the 1 year return is 43.4%, with a very large 5 year gain of 282.9%. This performance may have changed how the market views its risk and potential. Recent coverage has focused on Crinetics Pharmaceuticals as a growth oriented...
HLSE:QTCOM
HLSE:QTCOMSoftware

European Undervalued Small Caps With Insider Action To Watch In January 2026

As the European markets navigate a period of mixed economic signals, with the pan-European STOXX Europe 600 Index showing resilience and Germany emerging from a two-year recession, small-cap stocks are gaining attention for their potential in this evolving landscape. In such conditions, identifying promising small-cap opportunities often involves looking at companies that demonstrate solid fundamentals and have insider activity that may indicate confidence in their future prospects.
OM:EPEN
OM:EPENElectronic

High Growth Tech Stocks to Watch in Europe January 2026

As of January 2026, the European market has shown resilience with the pan-European STOXX Europe 600 Index ending higher, buoyed by strong economic data and earnings results, while Germany's economy snapped a two-year recession with modest growth. In this context of mixed but promising signals for small-cap stocks and tech sectors, identifying high-growth tech stocks involves looking for companies that demonstrate robust innovation potential and adaptability to evolving market dynamics.
SWX:SDZ
SWX:SDZPharmaceuticals

European Stocks That May Be Trading Below Estimated Value In January 2026

As of January 2026, European markets have shown resilience, with the pan-European STOXX Europe 600 Index rising by 0.77%, buoyed by strong economic data and earnings results. In this context of mixed performance across major indices like Germany's DAX and France's CAC 40, identifying stocks that may be trading below their estimated value involves looking for companies with solid fundamentals that could benefit from ongoing economic recovery and favorable trade conditions.
OM:HUMBLE
OM:HUMBLEPersonal Products

European Growth Stocks With High Insider Ownership In January 2026

As of January 2026, the European market has shown resilience, with the pan-European STOXX Europe 600 Index ending higher due to solid economic data and earnings results. In this environment, growth companies with high insider ownership can be particularly appealing as they often demonstrate strong alignment between management and shareholder interests, which is crucial amid mixed market performances.